Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

How I approach B-lymphoblastic lymphoma in children.

  • Read more about How I approach B-lymphoblastic lymphoma in children.

Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.

  • Read more about Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.

The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

  • Read more about The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce.

Data standards in pediatric oncology: Past, present, and future.

  • Read more about Data standards in pediatric oncology: Past, present, and future.

Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series.

  • Read more about Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series.

Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

  • Read more about Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions.

Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

  • Read more about Subcutaneous panniculitis-like T-cell lymphomas with homozygous inheritance of HAVCR2 mutations in Vietnamese pedigrees.

Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

  • Read more about Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

Zinc deficiency and its association with treatment-related toxicity in children with cancer.

  • Read more about Zinc deficiency and its association with treatment-related toxicity in children with cancer.

A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

  • Read more about A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List